U.S. FDA finds widely used asthma drug impacts the brain
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co MRK.N may be linked to serious mental health problems for some patients, according to a scientific presentation reviewed by Reuters.
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co MRK.N may be linked to serious mental health problems for some patients, according to a scientific presentation reviewed by Reuters.